Navigation Links
VeroScience Late-Breaking Abstract on Cycloset (A Quick Release,Formulation of Bromocriptine Mesylate) Accepted for Poster,Presentation at American Diabetes Association 67th Scientific,Sessions

TIVERTON, R.I., June 18, 2007 /PRNewswire/ -- VeroScience, LLC, a privately held biotechnology and healthcare product development company, announced today that its late-breaking abstract has been accepted as a poster presentation at the 67th Scientific Sessions of the American Diabetes Association in Chicago, Ill. The abstract, entitled, "Effects of Timed Cycloset(TM) (A Quick Release Formulation of Bromocriptine Mesylate) Administration of Safety, Cardiovascular Event Rate, and Glycemic Control in Subjects with Type 2 Diabetes Receiving Diet, Oral Hypoglycemic, and/or Insulin Treatment Regimens," will be included in the category of Clinical Therapeutics/New Technology - Pharmacologic Treatment of Diabetes or its Complications and displayed Saturday, Sunday and Monday, June 23-25, in the General Poster Session in the Exhibit Hall.

VeroScience is also sponsoring a corporate symposium supported by its commercialization partner for Cycloset(TM), S2 Therapeutics, Inc., that will be held in conjunction with the American Diabetes Association's 67th Scientific Sessions. The symposium, entitled "Evolution, Hypothalamic Dopamine Neurochemistry, and Developing New Therapies for Insulin Resistance Syndrome and Type 2 Diabetes," will be held on Sunday, June 24th from 5:30-7:45 AM at the Hyatt Regency Chicago, Grand F/D South. Registration and breakfast are from 5:00-5:30 AM or you can register in advance at www.veroscience.com/ada2007registration.

Cycloset(TM), an oral, quick-release formulation of bromocriptine is a centrally-acting dopamine D2 receptor agonist that is being studied as a potential therapy in the treatment of type 2 diabetes.

VeroScience is a privately held biotechnology and healthcare product development company with main offices and laboratories in Tiverton, RI. VeroScience has a large patent portfolio tha
'"/>




Page: 1 2

Related medicine technology :

1. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
2. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
3. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
4. Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress
5. OXiGENE Abstracts Published in ASCO Program
6. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
7. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
8. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
9. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
10. Pro-Pharmaceuticals to Present Abstract at the International Society of Oncodevelopmental Biology and Medicine Conference
11. SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO
Post Your Comments:
(Date:9/23/2014)... -- FDNA® ( http://www.fdna.com ) ... at the 2014 ASHG meeting, booth #1035, in ... the latest version of Face2Gene - the only available ... Face2Gene facilitates the detection of facial dysmorphic features and ... The new version of Face2Gene includes new features, ...
(Date:9/23/2014)... 2014 According to the ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General ... Global Forecasts to 2019", published by MarketsandMarkets, studies the ... of 2014 to 2019. The market is expected ... of 9.6% from 2014 to 2019. ...
(Date:9/23/2014)... , Sept. 23, 2014  While proton therapy recently began in ... patent Ashya King , another case in the United ... as a young boy who was given just days to live now ... Logan Green of Arizona complained of ... journey of medical treatments that will conclude Sept. 23, when he completes ...
Breaking Medicine Technology:FDNA to Exhibit at ASHG2014 Presenting Face2Gene Integrated With London Medical Databases (LMD) Online 2Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 45-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 25-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 4
... MENLO PARK, Calif. , July 12 Crux Biomedical® ... of medical device and diagnostic companies. The survey, conducted by Medical Device ... issue. The purpose of the survey was to identify firms that have ... their respective products. , , ...
... OKLAHOMA CITY , July 12 For the second consecutive ... receive its prestigious R&D 100 Award.  Orthocare Innovations received this award for ... function of persons who have experienced lower limb loss, injury or disease. ... (Logo:   http://photos.prnewswire.com/prnh/20100712/DA33752LOGO ) ...
Cached Medicine Technology:Crux Biomedical Named One of Top 50 Companies to Watch 2Orthocare Innovations Receives Prestigious R&D 100 Award for Novel Web-Based Rehabilitation Outcomes Assessment System 2
(Date:9/23/2014)... September 23, 2014 Trevera provides ... market. Included are Oracle Managed Services , ... supports all versions of Oracle E-Business Databases ... , Trevera has announced a significant enhancement ... need help with their software technology management, project ...
(Date:9/23/2014)... September 23, 2014 The Sloane ... in Singapore and Malaysia providing advanced aesthetic dermatology ... powder to its impressive skin care repertoire. Specially ... skin’s defences against the evil forces of aging, ... glow simultaneously, this new addition is revolutionizing the ...
(Date:9/23/2014)... The University of North Carolina ... In the Piedmont Triad, announced today that Dr. ... the Center for Translational Biomedical Research (CTBR). Zhang, ... after nearly a decade at the U.S. Department ... Division. , “Our goal is to build ...
(Date:9/23/2014)... Dennis Thompson HealthDay ... -- Coupled with worldwide marches demanding action on climate ... altered weather patterns in the United States may soon ... arrest and other heat-related illnesses are expected to increase ... lead author Dr. Jonathan Patz, director of the Global ...
(Date:9/23/2014)... Randy Dotinga HealthDay Reporter ... using cholesterol-lowering drugs while in the hospital for a hemorrhagic ... more than four times more likely to survive than people ... People taking the commonly used drugs known as statins ... or to a rehabilitation facility, the study reports. When ...
Breaking Medicine News(10 mins):Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Former Department of Energy Scientist Joins UNCG as Co-director of Biomedical Research Center 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 2Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 3
... finds dexmedetomidine caused less delirium, , , TUESDAY, Dec. ... on patients who are hooked up to mechanical ... worry that too much sedation might slow down ... , Now, researchers report that by substituting a ...
... January 7, Discovery Health Presents Five Nights of Active, Viewing ... ... FIT TO LIVE -, SILVER SPRING, Md., Dec. 11 ... annual,weight loss and general wellness campaign-launches with a four-part,television event following ...
... ANGELES, Dec. 11 AIDS Healthcare,Foundation (AHF) today ... Mike Huckabee, for his stubbornness and,recent failure to ... Senate campaign in which he called for people ... population. At the time, Huckabee,told Associated Press in ...
... Calls on Every Candidate from Every Party to ... WASHINGTON, Dec. 11 AIDS Action released a,statement ... rewrite,his HIV/AIDS platform to ensure that the policies ... and end stigma against people,living with HIV. "Governor ...
... combination of bortezomib (Velcade) and two other drugs is ... diagnosed with multiple myeloma, a team headed by Dana-Farber ... the American Society of Hematology. , The three-pronged regimen ... as Rev/Vel/Dex has achieved an overall response rate ...
... quality of life, researchers say , , TUESDAY, Dec. 11 ... constraint-induced movement therapy, some stroke patients can have significant ... a better quality of life, a new study finds. ... the less-affected hand. This forced them to use their ...
Cached Medicine News:Health News:Newer Sedative Might Help Patients on Ventilators 2Health News:Newer Sedative Might Help Patients on Ventilators 3Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 2Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 3Health News:Overweight Twins Battle the Bulge and Gain A New Lease on Life in National Body Challenge: Twins Edition on Discovery Health 4Health News:Huckabee's Defense of Earlier, Alarmist AIDS Stance Shows Unsuitability for Presidency, Says AHF 2Health News:AIDS Action Calls on Huckabee to Follow HIV/AIDS Science 2Health News:3-drug combination 'extremely promising' as first-line therapy for multiple myeloma 2Health News:Stroke Rehab Technique Has Lasting Results 2Health News:Stroke Rehab Technique Has Lasting Results 3
Heine Beta 200 Streak Retinoscope 2.5v...
System, English (Continental cord), 230 VAC....
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Medicine Products: